Ieq Capital, LLC Organogenesis Holdings Inc. Transaction History
Ieq Capital, LLC
- $12.3 Billion
- Q1 2025
A detailed history of Ieq Capital, LLC transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Ieq Capital, LLC holds 18,393 shares of ORGO stock, worth $55,730. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,393Holding current value
$55,730% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ORGO
# of Institutions
142Shares Held
65.3MCall Options Held
15.3KPut Options Held
925-
Soleus Capital Management, L.P. Greenwich, CT12.5MShares$37.8 Million4.46% of portfolio
-
Morgan Stanley New York, NY12.1MShares$36.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$15.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.43MShares$13.4 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.1MShares$9.39 Million0.0% of portfolio
About Organogenesis Holdings Inc.
- Ticker ORGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 130,888,000
- Market Cap $397M
- Description
- Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...